Biohaven BHVN
NYSE BHVN
$14.64 -0.55 (-3.62%)
As of: Nov 12, 2026 · 11:06 AM EST

Biohaven (BHVN) Return on Invested Capital [ROIC] (2025 - 2026)

Updated

Biohaven's Return on Invested Capital [ROIC] was -239.63% in Q3 2026, up 6.99 percentage points from -246.61% a year earlier but down 63.16 percentage points from the prior quarter.

Analysis

Biohaven (BHVN) Return on Invested Capital [ROIC] (2025 - 2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Biohaven came in at -208.67%.

  • Quarterly Return on Invested Capital [ROIC] has moved between -275.01% (Q4 2025) and -176.47% (Q2 2026) over five years.
  • Per Business Quant data, BHVN's Return on Invested Capital [ROIC] in the three quarters before Q3 2026 was -176.47% (Q2 2026), -197.54% (Q1 2026) and -275.01% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Biohaven 2.28 Bn 1.18 Bn - -239.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -239.63%
Jun 30, 2026 -176.47%
Mar 31, 2026 -197.54%
Dec 31, 2025 -275.01%
Sep 30, 2025 -246.61%
API Access

Biohaven Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=BHVN&period=max&api_key=YOUR_API_KEY